Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 28, 2015 08:30 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. to Present at Skin Vaccination Summit in Switzerland

HERSHEY, Pa. and ROCKVILLE, Md., Aug. 28, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
June 16, 2015 12:18 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. Taps Micronaut to Visually Demonstrate Its LAMP-vax Programs

HERSHEY, Pa. and ROCKVILLE, Md., June 16, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
June 03, 2015 09:35 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. CEO, William Hearl, Ph.D. to Speak at 2015 BIO International Convention

HERSHEY, Pa. and ROCKVILLE, Md., June 3, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
May 13, 2015 09:35 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. Awarded $1.2M Department of Defense Grant for Development of ARA-LAMP-vax Peanut Allergy Vaccine

HERSHEY, Pa. and ROCKVILLE, Md., May 13, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
May 06, 2015 09:45 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics Names Louise Peltier as Vice President, Regulatory Affairs

HERSHEY, Pa. and ROCKVILLE, Md., May 6, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
May 04, 2015 11:06 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics Appoints Eric Winzer as Chief Financial Officer

HERSHEY, Pa. and ROCKVILLE, Md., May 4, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. (ITI), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
April 02, 2015 09:45 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics to Present at 15th Annual World Vaccine Congress

HERSHEY, Pa. and ROCKVILLE, Md., April 2, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company pioneering next-generation vaccines based on its...
March 31, 2015 09:40 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. Awarded SBIR Grant From NIH for Nanoplasmid Peanut Allergy Vaccine Development

HERSHEY, Pa. and ROCKVILLE, Md., March 31, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
March 25, 2015 12:26 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics Receives Positive Feedback From FDA Following Pre-IND Discussions for Its Proprietary Peanut Allergy Vaccine

HERSHEY, Pa., and ROCKVILLE, Md., March 25, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
March 09, 2015 07:00 ET | Source: Immunomic Therapeutics, Inc.

Immunomic Therapeutics to Present at BIO-Europe Annual Conference

HERSHEY, Pa. and ROCKVILLE, Md., March 9, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company developing vaccines based on its proprietary LAMP...